Planet Labs PBC (PL) is up 15.4% today. Here is some analysis on what might have caused this price movement.
Analysis: The sharp move appears to be driven mainly by a broad rally in space stocks rather than a new Planet-specific announcement on June 29. This could be because investors rotated back into the sector after a major M&A deal involving Rocket Lab, while Planet’s already strong June fundamentals gave traders another reason to buy the rebound.
Details:
Sources:
Planet Labs Investor Relations, SEC, Axios
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$PL Insider Trading Activity
$PL insiders have traded $PL stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $PL stock by insiders over the last 6 months:
- ASHLEY F. JOHNSON (President & CFO) has made 0 purchases and 4 sales selling 350,731 shares for an estimated $11,092,021.
- WILLIAM SPENCER MARSHALL (Co-Founder and CEO) sold 200,000 shares for an estimated $7,014,520
- ROBERT H SCHINGLER (Co-Founder Chief Strategy Off.) sold 73,683 shares for an estimated $2,584,357
- KRISTEN ROBINSON sold 47,835 shares for an estimated $1,289,631
- ITA M BRENNAN sold 36,500 shares for an estimated $1,237,579
- VIJAYA GADDE sold 20,000 shares for an estimated $535,350
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$PL Hedge Fund Activity
We have seen 255 institutional investors add shares of $PL stock to their portfolio, and 176 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMERICAN CENTURY COMPANIES INC added 5,733,394 shares (+7134.3%) to their portfolio in Q1 2026, for an estimated $160,248,362
- BLACKROCK, INC. added 5,235,560 shares (+25.9%) to their portfolio in Q1 2026, for an estimated $146,333,902
- ALLIANCEBERNSTEIN L.P. added 3,797,295 shares (+1578.9%) to their portfolio in Q1 2026, for an estimated $106,134,395
- D. E. SHAW & CO., INC. added 3,470,024 shares (+54.1%) to their portfolio in Q4 2025, for an estimated $68,428,873
- ALPHABET INC. added 3,306,252 shares (+10.4%) to their portfolio in Q1 2026, for an estimated $92,409,743
- UBS GROUP AG added 2,835,917 shares (+363.1%) to their portfolio in Q1 2026, for an estimated $79,263,880
- LORD, ABBETT & CO. LLC added 2,475,619 shares (+inf%) to their portfolio in Q1 2026, for an estimated $69,193,551
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$PL Analyst Ratings
Wall Street analysts have issued reports on $PL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/13/2026
To track analyst ratings and price targets for $PL, check out Quiver Quantitative's $PL forecast page.
$PL Price Targets
Multiple analysts have issued price targets for $PL recently. We have seen 8 analysts offer price targets for $PL in the last 6 months, with a median target of $37.5.
Here are some recent targets:
- Ryan Koontz from Needham set a target price of $53.0 on 06/05/2026
- Dan Ives from Wedbush set a target price of $50.0 on 06/05/2026
- Jeff Van Rhee from Craig-Hallum set a target price of $49.0 on 06/05/2026
- Anthony Valentini from Goldman Sachs set a target price of $20.0 on 04/20/2026
- John Godyn from Citigroup set a target price of $35.0 on 04/02/2026
- Kristine Liwag from Morgan Stanley set a target price of $35.0 on 03/25/2026
- Colin Canfield from Cantor Fitzgerald set a target price of $40.0 on 03/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.